首页> 外文期刊>Acta Haematologica >Serum cytokine profiles in hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation
【24h】

Serum cytokine profiles in hemophagocytic syndrome following allogeneic hematopoietic stem cell transplantation

机译:同种异体造血干细胞移植后噬血细胞综合征的血清细胞因子谱

获取原文
获取原文并翻译 | 示例
           

摘要

Hemophagocytic syndrome (HPS) is a rare and potentially fatal disorder characterized by hypercytokinemia caused by hyperactivation of CD8+ T lymphocytes and macrophages, and infiltration of these cells into organs [1]. Several clinical symptoms including cytopenias can be explained by overproduction of T helper 1 (Thl) cyto-kines including interferon-gamma, interleukin-2, and tumor necrosis factor-alpha [1, 2]. HPS can be generally classified according to the underlying etiology into familial or secondary to infectious agents, malignancy, or rheumatic diseases [1]. Although it has been assumed that genetic or acquired cytotoxic defects of natural killer T cells and cytotoxic T cells and immune dysregulation may play a key role in the pathogenesis, the exact mechanism remains unclear.
机译:噬血细胞综合征(HPS)是一种罕见且可能致命的疾病,其特征在于由CD8 + T淋巴细胞和巨噬细胞的过度活化以及这些细胞向器官的浸润引起的高细胞血症[1]。包括血细胞减少症在内的几种临床症状可以通过产生T辅助1(Th1)细胞因子,包括干扰素-γ,白介素-2和肿瘤坏死因子-α来解释[1,2]。 HPS一般可根据其病因分类为家族性或继发于传染原,恶性肿瘤或风湿性疾病[1]。尽管已经假定天然杀伤性T细胞和细胞毒性T细胞的遗传或获得性细胞毒性缺陷以及免疫失调可能在发病机理中起关键作用,但确切的机制仍不清楚。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号